Examine This Report on conolidine
Andy Chevigné and his staff, RTI-5152-12 is postulated to increase the levels of opioid peptides that bind to classical opioid receptors in the brain, resulting in heightened painkilling activity. The LIH-RTI study teams recognized a collaboration settlement and submitted a joint patent application in December 2020.Conolidine CONOCB2™, that has